HomeAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$1.79
Makalipas ang Oras ng Trabaho:(1.73%)-0.031
$1.76
Sarado: Nob 5, 7:32:29 PM GMT-5 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.60
Sakop ng araw
$1.55 - $1.82
Sakop ng taon
$1.55 - $20.35
Market cap
4.95M USD
Average na Volume
130.39K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 25.00K | -50.00% |
Gastos sa pagpapatakbo | 2.66M | -28.77% |
Net na kita | -2.79M | -52.18% |
Net profit margin | -11.18K | -204.36% |
Kita sa bawat share | -3.68 | -22.67% |
EBITDA | -2.59M | 28.68% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 835.00K | -91.70% |
Kabuuang asset | 4.13M | -73.73% |
Kabuuang sagutin | 10.68M | 11.05% |
Kabuuang equity | -6.55M | — |
Natitirang share | 2.71M | — |
Presyo para makapag-book | -0.19 | — |
Return on assets | -127.49% | — |
Return on capital | 260.64% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.79M | -52.18% |
Cash mula sa mga operasyon | -1.53M | 49.10% |
Cash mula sa pag-invest | 754.00K | -8.72% |
Cash mula sa financing | 355.00K | -85.46% |
Net change in cash | -422.00K | -262.93% |
Malayang cash flow | -1.37M | 65.91% |
Tungkol
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Itinatag
1966
Headquarters
Website
Mga Empleyado
22
